Solsten Diagnostics International ApS

Company for innovative medical diagnostics

Our vision is to provide an easy applicable technology, which can be used for quickly and accurately detect any type of diagnostic target in a variety of relevant samples. 

Our mission is to develop, optimize, and commercialize the AptaSystem® technology. 

Our background Flusens ApS was spun-out from the Technical University of Denmark in 2014 with a focus on development of diagnostics for influenza virus infections. In order to emphasize the much wider diagnostic applicability of the Company’s core AptaSystem® technology, the company name was changed to Solsten (“sunstone”). According to legends, a sunstone could be used as a simple, yet mobile and advanced medieval navigational instrument, which could locate the sun in a completely overcast sky, and thereby facilitate fast and pivotal decisions.  

Solsten Diagnostics International ApS was privately acquired in April 2019, and its inventory includes a biosafety class 2 laboratory facilitating development and testing of pathogenic targets, and a semi-automated pilot production line for AptaChip®.